Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 61, Number 2, July 22, 2003
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarsy, D.
Right arrow Articles by Norregaard, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarsy, D.
Right arrow Articles by Norregaard, T.
Related Collections
Right arrow Multiple system atrophy
Right arrow Surgery/Stimulation

Neurology 2003;61:247-249
© 2003 American Academy of Neurology
Brief Communications

Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy

Daniel Tarsy, MD, Diana Apetauerova, MD, Patricia Ryan, MS and Thorkild Norregaard, MD

From the Department of Neurology, Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Address correspondence and reprint requests to Dr. Daniel Tarsy, Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail: dtarsy{at}bidmc.harvard.edu

A 59-year-old woman with levodopa-responsive parkinsonism complicated by motor fluctuations and generalized levodopa dyskinesia underwent bilateral subthalamic deep brain stimulation (STN DBS) 7 years after symptom onset. DBS improved levodopa-responsive upper extremity bradykinesia but aggravated speech, swallowing, and gait. Motor fluctuations were not improved and levodopa dose remained unchanged. Pulse generators were turned off. Clinical features and brain MRI in this case were indicative of multiple system atrophy (MSA). STN DBS is not recommended for patients with MSA.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
M. S. Okun, M. Tagliati, M. Pourfar, H. H. Fernandez, R. L. Rodriguez, R. L. Alterman, and K. D. Foote
Management of Referred Deep Brain Stimulation Failures: A Retrospective Analysis From 2 Movement Disorders Centers
Arch Neurol, August 1, 2005; 62(8): 1250 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. Bonneville, M. L. Welter, C. Elie, S. T. du Montcel, D. Hasboun, C. Menuel, J. L. Houeto, A. M. Bonnet, V. Mesnage, B. Pidoux, et al.
Parkinson disease, brain volumes, and subthalamic nucleus stimulation
Neurology, May 10, 2005; 64(9): 1598 - 1604.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.